학술논문
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives
Document Type
Article
Author
Source
In Value in Health Regional Issues December 2015 8:36-42
Subject
Language
ISSN
2212-1099